These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6617839)

  • 41. [Interaction with cytochrome P-450 as one of the mechanisms of protective action of 3-hydroxypyridines in the diethylnitrosamine poisoning of animals].
    Shuliakovskaia TS; Arshinov VIu; Pakhomov VIu; Rykova VA; Smirnov LD
    Izv Akad Nauk SSSR Biol; 1984; (6):950-3. PubMed ID: 6520298
    [No Abstract]   [Full Text] [Related]  

  • 42. [Method of quantitative determination of cytochrome P-450 in mouse liver homogenate].
    Cong Z
    Zhong Yao Tong Bao; 1984 Mar; 9(2):87-9. PubMed ID: 6235952
    [No Abstract]   [Full Text] [Related]  

  • 43. Urinary D-glucaric acid excretion and total liver content of cytochrome P-450 in guinea-pigs: relationship during enzyme induction and following inhibition of protein synthesis.
    Hunter J; Maxwell JD; Stewart DA; Williams R
    Biochem Pharmacol; 1973 Mar; 22(6):743-7. PubMed ID: 4693495
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunologically mediated toxicity.
    Amos HE
    Ciba Found Symp; 1980; 76():245-59. PubMed ID: 6780279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of cyclophosphamide in mouse limb bud cultures using a reconstituted cytochrome P-450 system.
    Kastner M; Blankenburg G; Schulz T; Schack G; Neubert D
    Arch Toxicol; 1988; 61(6):426-32. PubMed ID: 3190440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dependence of the embryotoxic action of dioxidine and cyclophosphamide on the immunoreactivity of the maternal-fetal system in mice].
    Torchinskiĭ AM; Chirkova EM; Koppel' MA; Gribunova GP
    Farmakol Toksikol; 1985; 48(1):69-73. PubMed ID: 3979541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in the cytochrome P-450 content of the liver of congenic resistant mouse strains during chronic alcoholization].
    Shoshina SV; Chistiakov VV; Maĭskiĭ AI
    Biull Eksp Biol Med; 1984 Dec; 98(12):685-7. PubMed ID: 6542440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of papain and levamisole on the body's immunological indices and oxidation-reduction processes in experimental sensitization].
    Kartoziia TsI; Viksman ME; Mchedlishvili MA; Baskanchiladze GSh; Ermak IS
    Antibiot Med Biotekhnol; 1986 Aug; 31(8):611-4. PubMed ID: 3767338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reversal of the depressive power of cyclophosphamide on the anti-infectious defense of the mouse by means of a somatic antigen from Bacillus subtilis].
    Lallouette P; Schwartz A; Dhennin L
    C R Seances Soc Biol Fil; 1976; 170(4):765-8. PubMed ID: 137039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice.
    Gibson JE; Becker BA
    Teratology; 1968 Nov; 1(4):393-8. PubMed ID: 4992685
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of inducers of mixed-function microsomal oxidases on the immune response of mice induced by heterologous erythrocytes].
    Kovalev IE; Borisova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):42-6. PubMed ID: 7269901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The influecing of specific and unspecific immunobiological reactions through cytostatics].
    Wilde J; Schabinski G
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 144(3):250-7. PubMed ID: 4968516
    [No Abstract]   [Full Text] [Related]  

  • 53. Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture system.
    Kitchin KT; Schmid BP; Sanyal MK
    Biochem Pharmacol; 1981 Jan; 30(1):59-64. PubMed ID: 7213412
    [No Abstract]   [Full Text] [Related]  

  • 54. [Reciprocal action between caffeine, other stimulants and drugs].
    Czok G
    Z Ernahrungswiss; 1980 Dec; 19(4):290-5. PubMed ID: 7467488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenobarbital modifies antitumor effect of cyclophosphamide depending on the type of tumor cell death caused by it.
    Kaledin VI; Nikolin VP; Baimak TY; Galyamova MR; Popova NA; Andreeva EM
    Bull Exp Biol Med; 2003 Mar; 135(3):289-92. PubMed ID: 12802404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation by a human interferon of antitumor effects of cyclophosphamide against a lymphosarcoma in hamsters.
    Lee SH; Chiu H; Renton KW; Stebbing N
    Biochem Pharmacol; 1984 Nov; 33(21):3439-43. PubMed ID: 6548630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of metabolism--mediated cytotoxicity by 1,1-disubstituted hydrazines in mouse mastocytoma cells (line P815).
    Wiebkin P; Hines RN; Nelson RE; Prough RA
    Adv Exp Med Biol; 1981; 136 Pt B():1067-75. PubMed ID: 7344500
    [No Abstract]   [Full Text] [Related]  

  • 58. [Influence of phenobarbital on the immunodepressive action of antitumor substances].
    Kovalev IE; Rubtsova ER; Shaĭdrov VV
    Vopr Onkol; 1976; 22(6):71-5. PubMed ID: 969346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 4-Ketocyclophosphamide, a metabolite of cyclophosphamide. Formation, chemical and biological properties.
    Hohorst HJ; Ziemann A; Brock N
    Arzneimittelforschung; 1971 Aug; 21(8):1254-7. PubMed ID: 5110030
    [No Abstract]   [Full Text] [Related]  

  • 60. Toxicity testing in vitro. II. Use of a microsome - cultured human fibroblast system to study the cytotoxicity of cyclophosphamide.
    Cooper JT; Goldstein S
    Can J Physiol Pharmacol; 1976 Aug; 54(4):546-50. PubMed ID: 974882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.